Document is current
Any future updates will be listed below
-
Authors
Hayashi, Kanna
Singh Kelsall, Tyson
Shane, Caitlin
Cui, Zishan
,
Milloy, M.-J.
DeBeck, Kora
Kerr, Thomas
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (U01DA038886, U01DA021525)
Michael Smith Foundation for Health Research
St. Paul’s Foundation
Canada Graduate Scholarships Doctoral program
- License Information
-
More Information
Article History
Received: 3 April 2023
Accepted: 17 July 2023
First Online: 30 August 2023
Declarations
:
: All three cohort studies (VIDUS, ACCESS, and ARYS) received ethics approval from the Providence Health Care/University of British Columbia Research Ethics Board (H14-01396 and H05-50233). Additionally, the Simon Fraser University Research Ethics Board (20190503) approved the present study. All participants provided written informed consent.
: Not applicable.
: MJM’s institution has received an unstructured gift from NG Biomed, Ltd., to support his research. MJM is the Canopy Growth professor of cannabis science at the University of British Columbia, a position created by unstructured gifts to the university from Canopy Growth, a licenced producer of cannabis, and the Government of British Columbia’s Ministry of Mental Health and Addictions. The funder that supports MJM did not have any role in study design; collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication. All authors declare no competing interests.
